Sources | Names Used |
---|---|
CTRPv2 | BRD-K19103580 |
PharmacoGx | BRD-K19103580 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIR3DL2 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | GHRH | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
mRNA | KIR3DL1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | AKAIN1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
mRNA | RASGEF1B | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
mRNA | SLC35D3 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | LGALS14 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | KLHL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
mRNA | KIR2DL3 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | RALYL | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |